Literature DB >> 21525382

Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia.

Emanuela M Ghia1, George F Widhopf, Laura Z Rassenti, Thomas J Kipps.   

Abstract

Chronic lymphocytic leukemia (CLL) cells that use IgH encoded by IGHV3-21 and that have a particular stereotypic third CDR (HCDR3), DANGMDV (motif-1), almost invariably express Ig L chains (IgL) encoded by IGLV3-21, whereas CLL that use IGHV3-21-encoded IgH with another stereotypic HCDR3, DPSFYSSSWTLFDY (motif-2), invariably express κ-IgL encoded by IGKV3-20. This nonstochastic pairing could reflect steric factors that preclude these IgH from pairing with other IgL or selection for an Ig with a particular Ag-binding activity. We generated rIg with IGHV3-21-encoded IgH with HCDR3 motif-1 or -2 and IgL encoded by IGKV3-20 or IGLV3-21. Each IgH paired equally well with matched or mismatched κ- or λ-IgL to form functional Ig, which we screened for binding to an array of different Ags. Ig with IGLV3-21-encoded λ-IgL could bind with an affinity of ∼ 2 × 10(-6) M to protein L, a cell-wall protein of Peptostreptococcus magnus, independent of the IgH, indicating that protein L is a superantigen for IGLV3-21-encoded λ-IgL. We also detected Ig binding to cofilin, a highly conserved actin-binding protein. However, cofilin binding was independent of native pairing of IgH and IgL and was not specific for Ig with IgH encoded by IGHV3-21. We conclude that steric factors or the binding activity for protein L or cofilin cannot account for the nonstochastic pairing of IgH and IgL observed for the stereotypic Ig made by CLL cells that express IGHV3-21.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525382      PMCID: PMC7015129          DOI: 10.4049/jimmunol.0902875

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Proteins of the ADF/cofilin family: essential regulators of actin dynamics.

Authors:  J R Bamburg
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Regulation of immunoglobulin biosynthesis in the murine plasmacytoma MOPC 315.

Authors:  G R Siebert; J F Harris; M L Gefter
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

3.  Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Authors:  Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Z Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti R Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas J Kipps
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

4.  Absence of preferential homologous H/L chain association in hybrid hybridomas.

Authors:  W B De Lau; K Heije; J J Neefjes; M Oosterwegel; E Rozemuller; B J Bast
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

5.  Frequent occurrence of identical heavy and light chain Ig rearrangements.

Authors:  K J Seidl; J D MacKenzie; D Wang; A B Kantor; E A Kabat; L A Herzenberg; L A Herzenberg
Journal:  Int Immunol       Date:  1997-05       Impact factor: 4.823

6.  Pairing of VH gene families with the lambda 1 light chain: evidence for a non-stochastic association.

Authors:  V V Yurovsky; G Kelsoe
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

7.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Authors:  Thomas Tiller; Eric Meffre; Sergey Yurasov; Makoto Tsuiji; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Immunol Methods       Date:  2007-10-31       Impact factor: 2.303

8.  Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Anastasia Hadzidimitriou; Tatjana Smilevska; Evangelia Kalagiakou; Katerina Hatzi; Niki Stavroyianni; Anastasia Athanasiadou; Aliki Tsompanakou; Theodora Papadaki; Garyfallia Kokkini; George Paterakis; Riad Saloum; Nikolaos Laoutaris; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

9.  Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients.

Authors:  G J Silverman; R Srikrishnan; K Germar; C S Goodyear; K A Andrews; E M Ginzler; B P Tsao
Journal:  Clin Exp Immunol       Date:  2008-05-28       Impact factor: 4.330

10.  Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues.

Authors:  Ki-Jong Rhee; Paul J Jasper; Periannan Sethupathi; Malathy Shanmugam; Dennis Lanning; Katherine L Knight
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

View more
  5 in total

1.  Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.

Authors:  Benjamin L Lampson; Siddha N Kasar; Tiago R Matos; Elizabeth A Morgan; Laura Rassenti; Matthew S Davids; David C Fisher; Arnold S Freedman; Caron A Jacobson; Philippe Armand; Jeremy S Abramson; Jon E Arnason; Thomas J Kipps; Joshua Fein; Stacey Fernandes; John Hanna; Jerome Ritz; Haesook T Kim; Jennifer R Brown
Journal:  Blood       Date:  2016-05-31       Impact factor: 22.113

2.  Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements.

Authors:  Davide Bagnara; Monica Colombo; Daniele Reverberi; Serena Matis; Rosanna Massara; Niccolò Cardente; Gianluca Ubezio; Vanessa Agostini; Luca Agnelli; Antonino Neri; Martina Cardillo; Stefano Vergani; Fabio Ghiotto; Andrea Nicola Mazzarello; Fortunato Morabito; Giovanna Cutrona; Manlio Ferrarini; Franco Fais
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia.

Authors:  A F Muggen; S Y Pillai; L P Kil; M C van Zelm; J J M van Dongen; R W Hendriks; A W Langerak
Journal:  Leukemia       Date:  2014-06-11       Impact factor: 11.528

Review 4.  The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia.

Authors:  Elisa Ten Hacken; Maria Gounari; Paolo Ghia; Jan A Burger
Journal:  Leukemia       Date:  2018-12-16       Impact factor: 11.528

5.  Responsiveness of chronic lymphocytic leukemia cells to B-cell receptor stimulation is associated with low expression of regulatory molecules of the nuclear factor-κB pathway.

Authors:  Ruud W J Meijers; Alice F Muggen; Leticia G Leon; Maaike de Bie; Jacques J M van Dongen; Rudi W Hendriks; Anton W Langerak
Journal:  Haematologica       Date:  2019-05-16       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.